Основная статистика
| CIK | 1385187 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| February 27, 2015 |
Form 15 OMB APPROVAL OMB Number: 3235-0167 Expires: February 28, 2015 Estimated average burden hours per response 1. |
|
| February 11, 2015 |
COV / / VANGUARD GROUP INC Passive Investment covidienplc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 0 )* Name of issuer: Covidien PLC Title of Class of Securities: Common Stock CUSIP Number: G2554F113 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box to designat |
|
| February 3, 2015 |
EX-3.1 Exhibit 3.1 “A” COMPANIES ACTS, 1963 to 2013 A PUBLIC COMPANY LIMITED BY SHARES MEMORANDUM and ARTICLES OF ASSOCIATION of COVIDIEN PUBLIC LIMITED COMPANY (As amended by Special Resolution dated 13 March 2012, 20 March 2013, 6 January 2015 and 28 January 2015) Incorporated A & L Goodbody Solicitors “A” COMPANIES ACTS, 1963 to 2013 A PUBLIC COMPANY LIMITED BY SHARES MEMORANDUM OF ASSOCIATION |
|
| February 3, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 28, 2015 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorpora |
|
| January 30, 2015 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on February 10, 2015, pursuant to the provisions of Rule 12d2-2 (a). |
|
| January 27, 2015 |
COV / S-8 POS - - FORM S-8 POS (333-158332) Form S-8 POS (333-158332) As filed with the Securities and Exchange Commission on January 26, 2015 Registration Nos. |
|
| January 27, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 26, 2015 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorpora |
|
| January 27, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 26, 2015 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorpora |
|
| January 27, 2015 |
COV / S-8 POS - - FORM S-8 POS (333-144309) Form S-8 POS (333-144309) As filed with the Securities and Exchange Commission on January 26, 2015 Registration Nos. |
|
| January 27, 2015 |
COV / S-8 POS - - FORM S-8 POS (333-190012) Form S-8 POS (333-190012) As filed with the Securities and Exchange Commission on January 26, 2015 Registration Nos. |
|
| January 27, 2015 |
Ex-4.1 Exhibit 4.1 NINTH SUPPLEMENTAL INDENTURE dated as of January 26, 2015, among Covidien International Finance S.A., a Luxembourg company (the “Company”), Covidien Ltd., a Bermuda company (“CLTD”), Covidien plc, a public limited company incorporated under the laws of Ireland (“CPLC” and, together with CLTD, the “Current Guarantors”), Medtronic plc, a public limited company incorporated under t |
|
| January 27, 2015 |
As filed with the Securities and Exchange Commission on January 26, 2015 POSASR As filed with the Securities and Exchange Commission on January 26, 2015 Registration No. |
|
| January 27, 2015 |
COV / S-8 POS - - FORM S-8 POS (333-144370) Form S-8 POS (333-144370) As filed with the Securities and Exchange Commission on January 26, 2015 Registration Nos. |
|
| January 27, 2015 |
EX-99.1 Exhibit 99.1 DUBLIN, Ireland — Jan. 26, 2014— Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the scheme of arrangement under which Medtronic acquired Covidien under a new holding company incorporated in Ireland to be named Medtronic plc has become effective. Covidien shareholders will receive the consideration to which they are entitled under the s |
|
| January 26, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - ACQUISITION FINAL PRESS RELEASE Form 425 - Acquisition Final Press Release Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 26, 2015 MEDTRONIC’S PENDING ACQUISITION OF COVIDIEN APPROVED BY IRISH HIGH COURT Transaction A |
|
| January 23, 2015 |
COV FORM 10-Q (Quarterly Report) COV-2015.12.26.14-10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 26, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-33259 (Commission File Number) COVIDIEN PUBLIC LIMITED COMP |
|
| January 22, 2015 |
Covidien Reports First-Quarter 2015 Results Exhibit 99.1 Covidien Reports First-Quarter 2015 Results • First-quarter net sales up 2% (up 6%, excluding foreign exchange rate movement) • First-quarter diluted GAAP earnings per share were $1.12; excluding specified items, adjusted diluted earnings per share were $1.11 DUBLIN, Ireland - January 22, 2015 - Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal |
|
| January 22, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2015 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other Jurisdiction of Incorporation) (Co |
|
| January 22, 2015 |
COV FORM 10-K AMENDMENT NO. 1 (Annual Report) Form 10-K Amendment No. 1 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 26, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-33259 (Commissi |
|
| January 21, 2015 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| January 20, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 20, 2015 20 January 2015 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Relevant Securities in Issue In accord |
|
| January 20, 2015 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| January 20, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - EMPLOYEE EMAIL Form 425 - Employee Email Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 20, 2015 From: RS Corporate Communications Sent: Tuesday, January 20, 2015 9:03 AM Subject: What to Expect Next: |
|
| January 16, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - EMPLOYEE STOCK PURCHASE PLAN: BLACKOUT PERIOD Form 425 - Employee Stock Purchase Plan: Blackout Period Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 16, 2015 Employee Stock Purchase Plan: Blackout Period Begins at Market Close Tue |
|
| January 14, 2015 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| January 13, 2015 |
Form 425 - Transcript - Medtronic, Inc. Presentation at the 33rd Annual JP Morgan Healthcare Conference Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 13, 2015 Medtronic, Inc. Presentat |
|
| January 12, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - MEDTRONIC PRESS RELEASE Form 425 - Medtronic Press Release Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 12, 2015 NEWS RELEASE Contacts: Cindy Resman Jeff Warren Public Relations Investor Relations +1-763-505 |
|
| January 12, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 12, 2015 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorpora |
|
| January 12, 2015 |
COV / 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 12, 2015 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorpora |
|
| January 12, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INTEGRATION PLAN Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 12, 2015 Integration Planning Continues at Recent Summit Leaders from both Medtronic and Covidien came together in mid-December to further |
|
| January 12, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Form 425 - Rule 2.10 Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 12, 2015 12 January 2015 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules Rele |
|
| January 12, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - BRYAN HANSON INTERVIEW Form 425 - Bryan Hanson Interview Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 12, 2015 New Medtronic Leader Interview with Bryan Hanson What Makes a Successful Organization? First |
|
| January 12, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - JP MORGAN HEALTHCARE CONFERENCE Form 425 - JP Morgan Healthcare Conference Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 12, 2015 |
|
| January 9, 2015 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| January 9, 2015 |
Medtronic Shareholders Approve Proposals Related to Medtronic’s Acquisition of Covidien EX-99.1 2 d849350dex991.htm EX-99.1 Exhibit 99.1 Medtronic Shareholders Approve Proposals Related to Medtronic’s Acquisition of Covidien MINNEAPOLIS – Jan. 6, 2015 – Medtronic, Inc. (NYSE: MDT) announced that all proposals related to Medtronic’s acquisition of Covidien were approved by Medtronic’s shareholders today. Based on preliminary vote results, the proposal to adopt the transaction agreemen |
|
| January 9, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 6, 2015 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commission |
|
| January 8, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Form 425 - Rule 2.10 Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 8, 2015 8 January 2015 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules Releva |
|
| January 8, 2015 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| January 6, 2015 |
EX-99.1 Exhibit 99.1 ANNOUNCEMENT UNDER IRISH TAKEOVER RULES THIS ANNOUNCEMENT IS BEING MADE SOLELY TO COMPLY WITH THE REQUIREMENTS OF THE IRISH TAKEOVER RULES. THE INFORMATION SET OUT HEREIN CONCERNING THE RESULTS OF COVIDIEN PLC’S SHAREHOLDER MEETINGS ON JANUARY 6, 2015 WILL ALSO BE SET OUT IN COVIDIEN PLC’S FORM 8-K TO BE FILED ON JANUARY 6, 2015 DUBLIN, Ireland – Jan. 6, 2015 – On January 6, 2 |
|
| January 6, 2015 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2015 COVIDIEN PUBLIC LIMITED COMPANY (Exact Name of Registrant as Specified in Charter) Ireland 001-33259 98-0624794 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I. |
|
| January 6, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INTRANET POSTING Form 425 - Intranet Posting Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 6, 2015 News & Announcements Medtronic and Covidien Shareholders Approve Acquisition January 6, 2015 Today, Me |
|
| January 6, 2015 |
EX-99.1 2 d847617dex991.htm EX-99.1 Exhibit 99.1 ANNOUNCEMENT UNDER IRISH TAKEOVER RULES THIS ANNOUNCEMENT IS BEING MADE SOLELY TO COMPLY WITH THE REQUIREMENTS OF THE IRISH TAKEOVER RULES. THE INFORMATION SET OUT HEREIN CONCERNING THE RESULTS OF COVIDIEN PLC’S SHAREHOLDER MEETINGS ON JANUARY 6, 2015 WILL ALSO BE SET OUT IN COVIDIEN PLC’S FORM 8-K TO BE FILED ON JANUARY 6, 2015 DUBLIN, Ireland – Ja |
|
| January 6, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - EMPLOYEE MEMORANDUM Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 6, 2015 Dear Colleagues, Earlier today, Medtronic and Covidien both announced preliminary shareholder approval of the pending acquisition |
|
| January 6, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - PRESS RELEASE SHAREHOLDER VOTE Form 425 - Press Release Shareholder Vote Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 6, 2015 Medtronic Shareholders Approve Proposals Related to Medtronic’s Acquisition of Covidien |
|
| January 6, 2015 |
COV / 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2015 COVIDIEN PUBLIC LIMITED COMPANY (Exact Name of Registrant as Specified in Charter) Ireland 001-33259 98-0624794 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I. |
|
| January 6, 2015 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| January 5, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT 425 1 d846036d425.htm FORM 425 - RULE 2.10 ANNOUNCEMENT Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 5, 2015 5 January 2015 Medtronic, Inc. Announcement under Rule 2.10 of the Irish T |
|
| January 5, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 2, 2015 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commission |
|
| January 2, 2015 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Form 425 - Rule 2.10 Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: January 2, 2015 2 January 2015 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Releva |
|
| December 30, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 23, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 23, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 23, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Form 425 - Rule 2.10 Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 23, 2014 23 December 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Re |
|
| December 23, 2014 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 23, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorporation |
|
| December 23, 2014 |
COV / 425 - Merger Prospectus - 8-K 425 1 d841592d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 23, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdic |
|
| December 22, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT 425 1 d841092d425.htm FORM 425 - RULE 2.10 ANNOUNCEMENT Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 22, 2014 19 December 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Iri |
|
| December 22, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - REFLECTIONS ON 2014 Form 425 - Reflections on 2014 Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 22, 2014 A Message from Omar Ishrak To: All WW Employees Subject: Reflections on 2014 Dear colleagues, As |
|
| December 17, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - ECONOMIC VALUE ARTICLE Form 425 - Economic Value Article Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 17, 2014 The Covidien Vision: To Deliver Unmatched Value, and More. Similar to Medtronic’s commitment t |
|
| December 17, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - MEDTRONIC REMINDER LETTER Form 425 - Medtronic Reminder Letter Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 17, 2014 December 17, 2014 Dear Fellow Shareholder, We have previously sent to you proxy materials f |
|
| December 17, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - SPECIAL MEETING REMINDER LETTER Form 425 - Special Meeting Reminder Letter Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 17, 2014 NOTICE - This is your reminder notice of the January 6, 2015 MEDTRONIC, INC. Special |
|
| December 16, 2014 |
Form 425 - FINALInsite Article - All Antitrust Clearances Obtained for Medtronic Filed by Medtronic, Inc. |
|
| December 16, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 16, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 16, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INTERVIEW MIKE GENAU Form 425 - Interview Mike Genau Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 15, 2014 “New Medtronic” Leader Interview with Mike Genau What is Your Background? MIKE GENAU: I’ve been |
|
| December 15, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - Q&A ABOUT COVIDIEN ACQUISITION Form 425 - Q&A About Covidien Acquisition Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 15, 2014 Questions and Answers About the Covidien Acquisition December 15, 2014 1. Does the rec |
|
| December 12, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 11, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - OPPENHEIMER HEALTHCARE CONFERENCE Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 11, 2014 Medtronic at the Oppenheimer Healthcare Conference December 10, 2014 Speaker: Gary Ellis Medtronic - EVP and CFO CONFERENCE CALL |
|
| December 11, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 11, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Form 425 - Rule 2.10 Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 11, 2014 11 December 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Re |
|
| December 10, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 10, 2014 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commissio |
|
| December 10, 2014 |
Exhibit 4.2 MEDTRONIC, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION, As Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of December 10, 2014 TO THE INDENTURE Dated as of December 10, 2014 FIRST SUPPLEMENTAL INDENTURE, dated as of December 10, 2014, between Medtronic, Inc., a corporation duly organized and existing under the laws of Minnesota (herein called the “Company”), and Wells Fargo Bank, Na |
|
| December 10, 2014 |
EX-4.10 Exhibit 4.10 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT dated December 10, 2014 (this “Agreement”) is entered into by and among Medtronic, Inc., a Minnesota corporation (the “Company”) and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC as representatives (the “Representatives”) of the several initial pu |
|
| December 10, 2014 |
EX-4.1 Exhibit 4.1 MEDTRONIC, INC. TO WELLS FARGO BANK, NATIONAL ASSOCIATION, As Trustee Indenture Dated as of December 10, 2014 TABLE OF CONTENTS* Page ARTICLE 1 Definitions and Other Provisions of General Application Section 1.01 Definitions 7 Section 1.02 Compliance Certificates and Opinions. 8 Section 1.03 Form of Documents Delivered to Trustee. 8 Section 1.04 Acts of Holders; Record Dates. 9 |
|
| December 9, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 9, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 8, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INTERVIEW CHRIS O'CONNELL 425 1 d834636d425.htm FORM 425 - INTERVIEW CHRIS O'CONNELL Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 8, 2014 “New Medtronic” Leader Interview with Chris O’Connell What Is Your Bac |
|
| December 8, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - COVIDIEN GLOBALIZATION ARTICLE FOR INSITE Form 425 - Covidien Globalization Article for Insite Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 8, 2014 Covidien: Expanding Global Access to Care With offices in 70 countries and s |
|
| December 5, 2014 |
COV / 425 - Merger Prospectus - 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 5, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 5, 2014 5 December 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Relevant Securities in Issue In accord |
|
| December 5, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 4, 2014 |
Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 4, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorporation |
|
| December 4, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 4, 2014 |
Medtronic Inc 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 4, 2014 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commission File |
|
| December 4, 2014 |
Chinese Ministry of Commerce Clears Medtronic Acquisition of Covidien EX-99.1 Exhibit 99.1 Chinese Ministry of Commerce Clears Medtronic Acquisition of Covidien MINNEAPOLIS AND DUBLIN, Ireland – Dec. 4, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Chinese Ministry of Commerce has cleared Medtronic’s proposed acquisition of Covidien. The proposed acquisition has also been cleared by the South Korean Fair Trade Commission an |
|
| December 4, 2014 |
COV / 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 4, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorporation |
|
| December 4, 2014 |
Chinese Ministry of Commerce Clears Medtronic Acquisition of Covidien EX-99.1 Exhibit 99.1 Chinese Ministry of Commerce Clears Medtronic Acquisition of Covidien MINNEAPOLIS AND DUBLIN, Ireland – Dec. 4, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Chinese Ministry of Commerce has cleared Medtronic’s proposed acquisition of Covidien. The proposed acquisition has also been cleared by the South Korean Fair Trade Commission an |
|
| December 4, 2014 |
Chinese Ministry of Commerce Clears Medtronic Acquisition of Covidien EX-99.1 Exhibit 99.1 Chinese Ministry of Commerce Clears Medtronic Acquisition of Covidien MINNEAPOLIS AND DUBLIN, Ireland – Dec. 4, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Chinese Ministry of Commerce has cleared Medtronic’s proposed acquisition of Covidien. The proposed acquisition has also been cleared by the South Korean Fair Trade Commission an |
|
| December 3, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Form 425 - Rule 2.10 Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 3, 2014 2 December 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Rele |
|
| December 2, 2014 |
Medtronic Inc 425 - Merger Prospectus - RULE 425 - RULE 2.10 ANNOUNCEMENT Rule 425 - Rule 2.10 Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 2, 2014 1 December 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Rele |
|
| December 2, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| December 1, 2014 |
COV / 425 - Merger Prospectus - FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 1, 2014 (November 28, 2014) COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other juris |
|
| December 1, 2014 |
Medtronic Inc 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 28, 2014 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commission Fil |
|
| December 1, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INTERVIEW WITH BOB WHITE Form 425 - Interview with Bob White Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: December 1, 2014 “New Medtronic” Leader Interview with Bob White What Is Your Background? I’ve been very fortu |
|
| December 1, 2014 |
European Commission Clears Medtronic Acquisition of Covidien EX-99.1 Exhibit 99.1 European Commission Clears Medtronic Acquisition of Covidien MINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the European Commission has conditionally cleared Medtronic’s proposed acquisition of Covidien. The clearance decision is conditional on Medtronic’s commitment to divest Covidien’s drug coat |
|
| December 1, 2014 |
Financial Statements and Exhibits, Other Events FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 1, 2014 (November 28, 2014) COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other juris |
|
| December 1, 2014 |
European Commission Clears Medtronic Acquisition of Covidien EX-99.1 Exhibit 99.1 European Commission Clears Medtronic Acquisition of Covidien MINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the European Commission has conditionally cleared Medtronic’s proposed acquisition of Covidien. The clearance decision is conditional on Medtronic’s commitment to divest Covidien’s drug coat |
|
| December 1, 2014 |
European Commission Clears Medtronic Acquisition of Covidien EX-99.1 Exhibit 99.1 European Commission Clears Medtronic Acquisition of Covidien MINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the European Commission has conditionally cleared Medtronic’s proposed acquisition of Covidien. The clearance decision is conditional on Medtronic’s commitment to divest Covidien’s drug coat |
|
| November 28, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 28, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - EC CLEARANCE Form 425 - EC Clearance Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 28, 2014 European Commission Clears Medtronic Acquisition of Covidien MINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, |
|
| November 28, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 26, 2014 |
Medtronic Acquisition of Covidien Receives U.S. FTC Clearance EX-99.1 Exhibit 99.1 Medtronic Acquisition of Covidien Receives U.S. FTC Clearance MINNEAPOLIS AND DUBLIN, Ireland – Nov. 26, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance of Medtronic’s proposed acquisition of Covidien. “This regulatory clearance represents an important milestone in bringing our compani |
|
| November 26, 2014 |
Medtronic Acquisition of Covidien Receives U.S. FTC Clearance EX-99.1 Exhibit 99.1 Medtronic Acquisition of Covidien Receives U.S. FTC Clearance MINNEAPOLIS AND DUBLIN, Ireland – Nov. 26, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance of Medtronic’s proposed acquisition of Covidien. “This regulatory clearance represents an important milestone in bringing our compani |
|
| November 26, 2014 |
Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 26, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorporation |
|
| November 26, 2014 |
Medtronic Inc 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 26, 2014 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 26, 2014 |
Medtronic Acquisition of Covidien Receives U.S. FTC Clearance EX-99.1 2 d825546dex991.htm EX-99.1 Exhibit 99.1 Medtronic Acquisition of Covidien Receives U.S. FTC Clearance MINNEAPOLIS AND DUBLIN, Ireland – Nov. 26, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance of Medtronic’s proposed acquisition of Covidien. “This regulatory clearance represents an important miles |
|
| November 26, 2014 |
COV / 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 26, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorporation |
|
| November 26, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 26, 2014 25 November 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Relevant Securities in Issue In acco |
|
| November 25, 2014 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to §240. |
|
| November 25, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INTERVIEW WITH MIKE COYLE Form 425 - Interview with Mike Coyle Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 25, 2014 “New Medtronic” Leader Interview with Mike Coyle What Is Your Background? So I’m an enginee |
|
| November 25, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - CIOS SHARE DETAILS ON INTEGRATION Form 425 - CIOs Share Details on Integration Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 25, 2014 Chief Information Officers Mike Hedges (Medtronic) and Steve McManama (Covidien) sh |
|
| November 25, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - FACT SHEET Form 425 - Fact Sheet Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 25, 2014 MEDTRONIC COVIDIEN ACQUISITION UPDATED FINANCING PLANS FACT SHEET November 25, 2014 Transaction Background |
|
| November 24, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 26, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-33259 (Commission File Number) COVIDIEN PUBLIC LIMITED COMPANY (Exact name of |
|
| November 24, 2014 |
COVIDIEN PLC SUBSIDIARIES OF THE REGISTRANT EX-21.1 2 cov2014092614ex-211.htm SUBSIDIARIES OF THE REGISTRANT Exhibit 21.1 COVIDIEN PLC SUBSIDIARIES OF THE REGISTRANT COUNTRY ENTITY NAME JURISDICTION Argentina Covidien Argentina S.A. Australia Auto Suture Holdings Pty Ltd Covidien Australia Pty Ltd Covidien Pty Limited ev3 Australia Pty Limited Given Imaging Pty Limited Lafayette Pharmaceuticals Pty Limited Medefield Pty Limited Panmedica Pt |
|
| November 21, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - MERGER BENEFIT STATEMENT Form 425 - Merger Benefit Statement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 21, 2014 MERGER BENEFIT STATEMENT November 20, 2014 Dear Covidien Shareholder On June 15, 2014, Medtr |
|
| November 21, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 21, 2014 |
COV / 425 - Merger Prospectus - FORM 425 Form 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 21, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - GLOBAL TOWN HALL TRANSCRIPT Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 20, 2014 Medtronic/Omar Ishrak Town Hall – 11/20/2014 OMAR ISHRAK: What I’m going to do now is to actually transition over to Covidien, a |
|
| November 21, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 21, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 21, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorpor |
|
| November 21, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - MEDTRONIC PROFIT FORECAST Form 425 - Medtronic Profit Forecast Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 21, 2014 MEDTRONIC PROFIT FORECAST November 20, 2014 Dear Covidien Shareholder On June 15, 2014, Med |
|
| November 21, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - OPTIONHOLDER LETTER Form 425 - Optionholder Letter Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 21, 2014 THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt about t |
|
| November 21, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 21, 2014 |
COV / 425 - Merger Prospectus - FORM 425 Form 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 21, 2014 |
COV / DEFM14A - - DEFINITIVE PROXY STATEMENT Definitive Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to §240. |
|
| November 21, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 20, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - GLOBAL TOWN HALL Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 20, 2014 Global Town Hall Meeting with Chairman and CEO Omar Ishrak November 20, 2014 The Medtronic Mission: A Shared Sense of Purpose To |
|
| November 20, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - ASIA ROADSHOW Form 425 - Asia Roadshow Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 20, 2014 CEO Roadshow Touches Down in Asia with Visits to Shanghai, China and Tokyo, Japan Joe Almeida and Omar |
|
| November 19, 2014 |
Form 425 - FAQ for Medtronic Shareholders on the Covidien Acquisition Filed by Medtronic, Inc. |
|
| November 18, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - EARNINGS MEMORANDUM Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 18, 2014 Dear Colleagues, This morning, we announced our fiscal year 2015 second quarter results. I’m extremely pleased with our performa |
|
| November 18, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INTERVIEW WITH ROBERT TENHOEDT Form 425 - Interview with Robert tenHoedt Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 18, 2014 “New Medtronic” Leader Interview with Rob ten Hoedt What is Your Background? I’m a Dut |
|
| November 18, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - MEDTRONIC Q2 FY15 EARNINGS CALL COMMENTARY Form 425 - Medtronic Q2 FY15 Earnings Call Commentary Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 18, 2014 Medtronic Q2 FY15 Earnings Call Commentary Investor Relations Commentary Q |
|
| November 17, 2014 |
Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015 EX-99.1 2 d822650dex991.htm EX-99.1 Exhibit 99.1 Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015 MINNEAPOLIS AND DUBLIN – Nov. 17, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) announced that following a hearding today before the Irish High Court the companies have scheduled shareholder meetings for Tuesday, January 6, 2015, in connection with the pendin |
|
| November 17, 2014 |
Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015 EX-99.1 Exhibit 99.1 Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015 MINNEAPOLIS AND DUBLIN – Nov. 17, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) announced that following a hearing today before the Irish High Court the companies have scheduled shareholder meetings for Tuesday, January 6, 2015, in connection with the pending acquisition of Covidien by |
|
| November 17, 2014 |
Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015 EX-99.1 2 d822650dex991.htm EX-99.1 Exhibit 99.1 Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015 MINNEAPOLIS AND DUBLIN – Nov. 17, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) announced that following a hearding today before the Irish High Court the companies have scheduled shareholder meetings for Tuesday, January 6, 2015, in connection with the pendin |
|
| November 17, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 17, 2014 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commissio |
|
| November 17, 2014 |
COV / 425 - Merger Prospectus - FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 17, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorpor |
|
| November 17, 2014 |
Financial Statements and Exhibits, Other Events 8-K 1 d822650d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 17, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jur |
|
| November 13, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INTEGRATION UPDATE Form 425 - Integration Update Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 13, 2014 Colleagues, Recently, I announced the structure of the new Medtronic organization and the Medtroni |
|
| November 13, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 13, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 13, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - LEADERSHIP STRUCTURE Form 425 - Leadership Structure Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 13, 2014 Leadership Structure Communications Summary FAQ How were these leaders/leadership teams chosen? |
|
| November 13, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 12, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - IMO SUMMIT RECAP Form 425 - IMO Summit Recap Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 12, 2014 Integration Planning Moves Ahead at Integration Summit #2 More than 90 leaders from Medtronic and Co |
|
| November 12, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 7, 2014 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commission |
|
| November 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other Jurisdiction of Incorporation) (Co |
|
| November 12, 2014 |
COV / 425 - Merger Prospectus - 425 425 1 d820011d425.htm 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Integration Planning Moves Ahead at Integration Summit #2 More than 90 leaders from Medtronic and Covidien came together in Minneapolis last week to attend |
|
| November 10, 2014 |
AMENDMENT AND RESTATEMENT AGREEMENT EX-10.3 Exhibit 10.3 EXECUTION VERSION AMENDMENT AND RESTATEMENT AGREEMENT This AMENDMENT AND RESTATEMENT AGREEMENT dated as of November 7, 2014 (this “Amendment Agreement”) is entered into by and among MEDTRONIC, INC., a Minnesota corporation (“Medtronic”), MEDTRONIC GLOBAL HOLDINGS SCA, a partnership limited by shares (société en commandite par actions) incorporated under the laws of the Grand-D |
|
| November 10, 2014 |
EX-10.1 2 d818956dex101.htm EX-10.1 Exhibit 10.1 EXECUTION VERSION Published CUSIP Number: 58505JAS5 SENIOR UNSECURED BRIDGE CREDIT AGREEMENT dated as of November 7, 2014 among MEDTRONIC, INC., as the Borrower, MEDTRONIC HOLDINGS LIMITED and MEDTRONIC GLOBAL HOLDINGS SCA, as Guarantors, the Lenders from time to time party hereto, and BANK OF AMERICA, N.A., as Administrative Agent, MERRILL LYNCH, P |
|
| November 10, 2014 |
EX-10.2 Exhibit 10.2 EXECUTION VERSION Published CUSIP Number: 58505JAN6 SENIOR UNSECURED TERM LOAN CREDIT AGREEMENT dated as of November 7, 2014 among MEDTRONIC, INC., as the Borrower, MEDTRONIC HOLDINGS LIMITED and MEDTRONIC GLOBAL HOLDINGS SCA, as Guarantors, the Lenders from time to time party hereto, and BANK OF AMERICA, N.A., as Administrative Agent, MERRILL LYNCH, PIERCE, FENNER & SMITH INC |
|
| November 10, 2014 |
Medtronic Inc 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 7, 2014 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commission File |
|
| November 10, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 7, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 7, 2014 |
Medtronic Inc 425 - Merger Prospectus - QUESTIONS AND ANSWERS ABOUT THE COVIDIEN ACQUISITION Questions and Answers About the Covidien Acquisition Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: November 7, 2014 Questions and Answers About the Covidien Acquisition November 7, 2014 1. Is |
|
| November 5, 2014 |
Covidien Reports Fourth-Quarter and Fiscal 2014 Results Exhibit 99.1 Covidien Reports Fourth-Quarter and Fiscal 2014 Results • Fourth-quarter net sales up 7%; Medical Devices sales up 8% • Fourth-quarter diluted GAAP earnings per share were $1.13; excluding specified items, adjusted diluted earnings per share were $1.15 • Fiscal 2014 diluted GAAP earnings per share were $3.65; excluding specified items, adjusted diluted earnings per share were $4.15, u |
|
| November 5, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 cov20141105148-k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or othe |
|
| November 5, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 3, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 3, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 3, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 3, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| November 3, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 31, 2014 |
COV / 425 - Merger Prospectus - 425 425 1 d813826d425.htm 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Week of October 27 Medtronic and Covidien Provide Update on Expected Close Date of Acquisition On October 30, Medtronic and Covidien confirmed that both co |
|
| October 30, 2014 |
COV / 425 - Merger Prospectus - 425 425 1 d811427d425.htm 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Video Script: N1/New ExCom Announcement Omar Ishrak, Chairman and CEO Good morning, good afternoon and good evening to all of you around the world. I’m ple |
|
| October 30, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2 10 LEGEND Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 30, 2014 29 October 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Relevant Securities in Issue In accord |
|
| October 30, 2014 |
COV / 425 - Merger Prospectus - 425 425 Table of Contents Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 30, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - EE MESSAGE Form 425 - EE Message Filed by Medtronic, Inc. (SEC File No.: 001-07707 pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 30, 2014 Dear Colleagues, Today, I want to communicate additional information about our proposed acquisition of Covid |
|
| October 30, 2014 |
8-K 1 d811411d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 29, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdict |
|
| October 30, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 29, 2014 Medtronic, Inc. (Exact name of registrant as specified in its charter) Minnesota 1-7707 41-0793183 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 30, 2014 |
COV / 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 29, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 001-33259 98-0624794 (State or other jurisdiction of incorporation |
|
| October 29, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - ST CONFERENCE Form 425 - ST Conference Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 28, 2014 Medtronic S&T Conference: Keynote Speech and Q & A Geoff Martha, Sr. Vice President, Business Developmen |
|
| October 24, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - FACT SHEET Form 425 - Fact Sheet Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 24, 2014 MEDTRONIC COVIDIEN ACQUISITION UPDATED FINANCING PLANS FACT SHEET October 24, 2014 Transaction Background O |
|
| October 24, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 24, 2014 |
8-K 1 cov-2014x1024148xk.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact name of registrant as specified in charter) Ireland 001-33259 98-0624794 (State or other |
|
| October 22, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - GROWTH ACCELERATION Form 425 - Growth Acceleration Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 22, 2014 Accelerating Growth Co-leaders of the Growth Acceleration integration planning workstream, Ellie P |
|
| October 21, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 21, 2014 |
COV / 425 - Merger Prospectus - 425 425 1 d809174d425.htm 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 October 21, 2014 Dear HR Colleagues: Integration planning for the acquisition is in full swing now, and the HR team is playing a key role in the process, a |
|
| October 21, 2014 |
COV / 425 - Merger Prospectus - 425 425 1 d807344d425.htm 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Global Business Announcement Questions and Answers October 21, 2014 1. Why are we changing the structure of the Medical Supplies, Respiratory & Monitoring |
|
| October 21, 2014 |
COV / 425 - Merger Prospectus - 425 425 1 d807364d425.htm 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Filer’s S-4 File No.: 333-197406 Talking Points Global Business Announcement October 21, 2014 Summary Statement Since being named Group President of Covidien business segments, Bryan Ha |
|
| October 21, 2014 |
COV / 425 - Merger Prospectus - 425 425 1 d807955d425.htm 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 S-4 Amendment 3 has been filed... Is this email not displaying correctly? View it in your browser. Members of the investment community: I wanted to make su |
|
| October 20, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - COV INNOVATION Form 425 - COV Innovation Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 20, 2014 Get to Know Covidien: Innovation in All That We Do Innovation comes in many forms at Covidien. “Innovat |
|
| October 17, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 17, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 10, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - OMAR EMP MSG Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 10, 2014 From: Omar Ishrak Sent: Friday, October 10, 2014 6:32 AM Subject: New Executive Leadership Team Upon Close of Covidien Acquisitio |
|
| October 10, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - EXECUTIVE BIOS Form 425 - Executive Bios Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 10, 2014 CHRIS J. OCONNELL Executive Vice President and Group President, Restorative Therapies Group Chris OCo |
|
| October 10, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 10, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INTERNAL FAQ Filed by Medtronic, Inc. (SEC File No.: 001-07707 pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 10, 2014 MEDTRONIC ANNOUNCES EXECUTIVE LEADERSHIP TEAM FOR COMBINED ORGANIZATION UPON CLOSE OF COVIDIEN ACQUISITION Internal FAQ 1) What wa |
|
| October 10, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 10, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - PRESS RELEASE Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 10, 2014 NEWS RELEASE Contacts: Fernando Vivanco Jeff Warren Public Relations Investor Relations +1-763-505-3780 +1-763-505-2696 FOR IMMED |
|
| October 10, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 10, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 10, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - OMAR ISHRAK VIDEO TRANSCRIPT Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 10, 2014 VIDEO SCRIPT: New Executive Leadership Team Announcement; Omar Ishrak, Medtronic Chairman and CEO Good morning, good afternoon an |
|
| October 10, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 8, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - ISHRAK WARREN LONDON INVESTOR MEETING London Investor Meetings October 8, 2014 Jeff Warren Vice President, Investor Relations jeff. |
|
| October 7, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 3, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| October 3, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - MDT PRESS RELEASE Form 425 - MDT Press Release Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 3, 2014 NEWS RELEASE Contacts: Fernando Vivanco Jeff Warren Public Relations Investor Relations +1-763-505-37 |
|
| October 3, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - DR OESTERLE Q&A Form 425 - Dr Oesterle Q&A Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 3, 2014 Trekking for Technology Dr. Steve Oesterle Shares His Quest for Innovation Q: Tell us about your role a |
|
| October 3, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - FACT SHEET Form 425 - Fact Sheet Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 3, 2014 MEDTRONIC COVIDIEN ACQUISITION UPDATED FINANCING PLANS FACT SHEET October 3, 2014 Transaction Background On |
|
| October 3, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - OMAR ISHRAK MEMORANDUM Form 425 - Omar Ishrak Memorandum Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 3, 2014 From: Omar Ishrak Sent: Friday, October 03, 2014 8:36 AM Subject: Important Update Regarding Cov |
|
| October 3, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - ROADSHOW Form 425 - Roadshow Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 3, 2014 CEO Roadshow Continues with Stops in Miami, Fla., U.S, Boulder, Colo., U.S and Zurich, Switzerland Joe Almeida |
|
| October 3, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - IR PRESENTATION Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: October 3, 2014 A Compelling Acquisition to Accelerate Medtronic’s Growth Strategies Updated October 3, 2014 NO OFFER OR SOLICITATION This communi |
|
| September 30, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 25, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INSITE GEOFF MARTHA TRANSCRIPT Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: September 25, 2014 Medtronic Geoff Martha Leadership Profile Senior V.P. and Chief Integration Officer Question 3 – Video 4 Blurb accompanying vid |
|
| September 24, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 23, 2014 |
EX-10.1 Exhibit 10.1 COVIDIEN SEVERANCE PLAN FOR U.S. OFFICERS AND EXECUTIVES As Amended and Restated Effective September 17, 2014 TABLE OF CONTENTS Page ARTICLE I PURPOSE, INTENT AND TERM OF PLAN 1 Section 1.01 Purpose and Intent of the Plan 1 Section 1.02 Term of the Plan 1 Section 1.03 Adoption of the Plan 1 ARTICLE II DEFINITIONS 2 Section 2.01 “Alternative Position” 2 Section 2.02 “Annual Bon |
|
| September 23, 2014 |
Covidien plc 2007 Stock and Incentive Plan TERMS AND CONDITIONS OPTION AWARD EX-10.2 3 d793386dex102.htm EX-10.2 Exhibit 10.2 Covidien plc 2007 Stock and Incentive Plan TERMS AND CONDITIONS OF OPTION AWARD OPTION AWARD granted on (the “Grant Date”). 1. Grant of Nonqualified Stock Option. Covidien plc (the “Company”) has granted to you a Nonqualified Stock Option to purchase the number of Ordinary Shares set forth in the Grant Letter that issued this Award to you, subject t |
|
| September 23, 2014 |
EX-10.1 Exhibit 10.1 COVIDIEN SEVERANCE PLAN FOR U.S. OFFICERS AND EXECUTIVES As Amended and Restated Effective September 17, 2014 TABLE OF CONTENTS Page ARTICLE I PURPOSE, INTENT AND TERM OF PLAN 1 Section 1.01 Purpose and Intent of the Plan 1 Section 1.02 Term of the Plan 1 Section 1.03 Adoption of the Plan 1 ARTICLE II DEFINITIONS 2 Section 2.01 “Alternative Position” 2 Section 2.02 “Annual Bon |
|
| September 23, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 23, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INSITE ZURICH PLANNING BOOT CAMP ARTICLE Form 425 - Insite Zurich Planning Boot Camp Article Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: September 22, 2014 InSite Zurich Integration Planning Boot Camp Article Medtronic and Covidien |
|
| September 23, 2014 |
8-K 1 d793386d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact Name of Registrant as Specified in Charter) Ireland 001-33259 98-0624794 (State or Other Juri |
|
| September 23, 2014 |
Covidien Ltd. 2007 Stock and Incentive Plan TERMS AND CONDITIONS OPTION AWARD EX-10.3 Exhibit 10.3 Covidien Ltd. 2007 Stock and Incentive Plan TERMS AND CONDITIONS OF OPTION AWARD OPTION AWARD granted on December 1, 2008 (the “Grant Date”). 1. Grant of Option. Covidien Ltd. (the “Company”) has granted to you an Option to purchase the number of Shares of Common Stock set forth in the Grant Letter that issued this Option to you, subject to the provisions of these Terms and Co |
|
| September 23, 2014 |
Covidien plc 2007 Stock and Incentive Plan TERMS AND CONDITIONS OPTION AWARD EX-10.2 Exhibit 10.2 Covidien plc 2007 Stock and Incentive Plan TERMS AND CONDITIONS OF OPTION AWARD OPTION AWARD granted on (the “Grant Date”). 1. Grant of Nonqualified Stock Option. Covidien plc (the “Company”) has granted to you a Nonqualified Stock Option to purchase the number of Ordinary Shares set forth in the Grant Letter that issued this Award to you, subject to the provisions of these Te |
|
| September 23, 2014 |
Covidien Ltd. 2007 Stock and Incentive Plan TERMS AND CONDITIONS OPTION AWARD EX-10.3 Exhibit 10.3 Covidien Ltd. 2007 Stock and Incentive Plan TERMS AND CONDITIONS OF OPTION AWARD OPTION AWARD granted on December 1, 2008 (the “Grant Date”). 1. Grant of Option. Covidien Ltd. (the “Company”) has granted to you an Option to purchase the number of Shares of Common Stock set forth in the Grant Letter that issued this Option to you, subject to the provisions of these Terms and Co |
|
| September 23, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 23, 2014 |
COV / 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2014 COVIDIEN PUBLIC LIMITED COMPANY (Exact Name of Registrant as Specified in Charter) Ireland 001-33259 98-0624794 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I. |
|
| September 23, 2014 |
Covidien Ltd. 2007 Stock and Incentive Plan TERMS AND CONDITIONS OPTION AWARD EX-10.4 Exhibit 10.4 Covidien Ltd. 2007 Stock and Incentive Plan TERMS AND CONDITIONS OF OPTION AWARD OPTION AWARD granted on July 2, 2007 (the “Grant Date”). 1. Grant of Option. Covidien Ltd. (the “Company”) has granted to you an Option to purchase the number of Shares of Common Stock set forth in the Grant Letter that issued this Option to you, subject to the provisions of these Terms and Condit |
|
| September 23, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 23, 2014 |
Covidien Ltd. 2007 Stock and Incentive Plan TERMS AND CONDITIONS OPTION AWARD EX-10.4 Exhibit 10.4 Covidien Ltd. 2007 Stock and Incentive Plan TERMS AND CONDITIONS OF OPTION AWARD OPTION AWARD granted on July 2, 2007 (the “Grant Date”). 1. Grant of Option. Covidien Ltd. (the “Company”) has granted to you an Option to purchase the number of Shares of Common Stock set forth in the Grant Letter that issued this Option to you, subject to the provisions of these Terms and Condit |
|
| September 22, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 19, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 19, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 18, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INSITE GEOFF MARTHA TRANSCRIPT Form 425 - Insite Geoff Martha Transcript Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: September 18, 2014 Medtronic Geoff Martha Leadership Profile Senior V.P. and Chief Integration Officer Q |
|
| September 18, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 17, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| September 10, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - INSITE GEOFF MARTHA VIDEO TRANSCRIPT Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: September 10, 2014 Geoff Martha Video #2 on Covidien Integration To publish live on InSite: 9.10.14 Statement on site accompanying video: Senior V |
|
| September 5, 2014 |
Form 425 - Geoff Martha Transcript of Text accompanying Video Filed by Medtronic, Inc. |
|
| September 4, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - BILL BURKE QA Form 425 - Bill Burke QA Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: September 4, 2014 Covidien’s Vice President for Integration, Bill Burke, on integration planning As plans move forward fo |
|
| August 29, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - WARREN-STOCKHOLM MARKETING Form 425 - Warren-Stockholm Marketing Stockholm Investor Meetings August 29, 2014 Ryan Weispfenning Senior Director, Investor Relations ryan. |
|
| August 28, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| August 27, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 ANNOUNCEMENT Form 425 - Rule 2.10 Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 27, 2014 26 August 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Releva |
|
| August 26, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| August 25, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - GLOBAL REWARDS FAQ Form 425 - Global Rewards FAQ Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 25, 2014 Frequently Asked Questions About Tax Implications of the Covidien Acquisition to all Global Medtroni |
|
| August 25, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - TOWN HALL MEETING TRANSCRIPT Form 425 - Town Hall Meeting Transcript Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 22, 2014 Transcript from a Town Hall Meeting held on 8/22/2014 OMAR ISHRAK: I think this set of sli |
|
| August 25, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - MEDTRONIC IMO REGIONAL ANNOUNCEMENT Form 425 - Medtronic IMO Regional Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 25, 2014 Dear Colleagues, Planning the combination of two companies the size and scope of Me |
|
| August 25, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - 2014 ANNUAL SHAREHOLDERS MEETING PRESENTATION 425 1 d779260d425.htm FORM 425 - 2014 ANNUAL SHAREHOLDERS MEETING PRESENTATION Omar Ishrak Chairman and CEO 2014 Annual Shareholders Meeting August 21, 2014 Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-19 |
|
| August 25, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - DRYDA 5 REASONS Form 425 - Dryda 5 Reasons Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 25, 2014 Explanatory note: This article was posted on www.beckersspine.com on August 20, 2014. 5 Reasons Why the |
|
| August 22, 2014 |
Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 22, 2014 1 THOMSON REUTERS STREETEVENTS | www.streetevents.com | Contact Us © 2014 Thomson Reuters. All rights reserved. Republication or r |
|
| August 22, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - GLOBAL TOWN HALL MEETING PRESENTATION Form 425 - Global Town Hall Meeting Presentation Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 22, 2014 Global Town Hall Meeting with Chairman and CEO Omar Ishrak August 22, 2014 Medtro |
|
| August 21, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - FIRST INTEGRATION PLANNING TEAM Form 425 - First Integration Planning Team Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 21, 2014 Medtronic and Covidien Leaders Come Together at First Integration Planning Team Boot Ca |
|
| August 21, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - PLANNING LEADERSHIP IMO ANNOUNCEMENT SUMMARY Form 425 - Planning Leadership IMO Announcement Summary Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 21, 2014 Integration Planning Team Leadership Announced The pending combination of |
|
| August 20, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - EARNINGS CALL TRANSCRIPT Form 425 - Earnings Call Transcript Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 19, 2014 Q1 2015 Medtronic, Inc. Earnings Call Transcript Date: August 19, 2014 Operator: Good morning. |
|
| August 19, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - MESSAGE FROM OMAR ISHRAK Form 425 - Message from Omar Ishrak Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 19, 2014 Colleagues, Today, we publicly released our fiscal year 2015 first quarter financial results. |
|
| August 18, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - IMO BU FUNCTIONAL ANNOUNCEMENT Form 425 - IMO BU Functional Announcement Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 18, 2014 Dear Colleagues, We are off to a positive start in planning the integration of Medtronic |
|
| August 18, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| August 15, 2014 |
Form 425 - Omar Ishrak Update on Proposed Covidien Acquisition Filed by Medtronic, Inc. |
|
| August 14, 2014 |
COV / 425 - Merger Prospectus - 425 425 Filed by Covidien plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No. |
|
| August 14, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - EARL BAKKEN MEMO Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 14, 2014 Greetings of Warm Aloha to You All, You probably know I’m a dreamer, always looking forward. And lately, I’ve been imagining some |
|
| August 13, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - RULE 2.10 Form 425 - Rule 2.10 Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 13, 2014 12 August 2014 Medtronic, Inc. Announcement under Rule 2.10 of the Irish Takeover Rules Relevant Securities |
|
| August 13, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - MEDTRONIC'S TAX LESSONS Form 425 - Medtronic's Tax Lessons Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form S-4 File No.: 333-197406 Date: August 13, 2014 12 August 2014 The Wall Street Journal Explanatory Note: This editorial was published by the Wa |
|
| August 12, 2014 |
Medtronic Inc 425 - Merger Prospectus - FORM 425 - LATAM MIAMI TOWN HALL Form 425 - LatAm Miami Town Hall Town Hall Meeting August 12, 2014 Omar Ishrak Chairman and CEO Medtronic, Inc. |
